LIPIDS: 60 Second Insights

Published: 10 August 2018

  • Views:

    Views Icon 11

  • Likes:

    Heart Icon 7
  • episode_image
    Now Playing
    Part 6 | Session 2 of 2
    Wolfgang Koenig
    Wolfgang Koenig
    Up Next
Average (ratings)
No ratings
Your rating

Overview

A short series of 60-second insight videos on the LIPIDS trial.

More from this programme

Part 1

Which emerging compounds show the most promise in reducing LDL?

2 sessions
Christopher Cannon Watch now
Wolfgang Koenig Watch now

Part 2

What is required for PCSK9s to get wider spread adoption?

2 sessions
Christopher Cannon Watch now
Wolfgang Koenig Watch now

Part 3

How important is inflammation in atherosclerosis?

2 sessions
Christopher Cannon Watch now
Wolfgang Koenig Watch now

Part 4

Are statins over (or under) prescribed?

2 sessions
Christopher Cannon Watch now
Wolfgang Koenig Watch now

Part 5

Is cholesterol being managed sub- optimally? If so, what needs to improve?

2 sessions
Christopher Cannon Watch now
Wolfgang Koenig Watch now

Part 6

How low should LDL go?

2 sessions
Christopher Cannon Watch now
Wolfgang Koenig Watch now

Part 7

Is HDL good cholesterol?

2 sessions
Christopher Cannon Watch now
Wolfgang Koenig Watch now

Part 8

What is the greatest unmet need in lipid management?

2 sessions
Christopher Cannon Watch now
Wolfgang Koenig Watch now

Faculty Biographies

Wolfgang Koenig

Wolfgang Koenig

Professor of Medicine/Cardiology

Professor of Medicine/Cardiology, a Consultant in Cardiology, Head of Clinical Research in the Department of Internal Medicine II – Cardiology, and Director of the Hypertension and Heart Failure Clinics and the Preventive Cardiology Program at the University of Ulm Medical Center, Germany.

Dr Koenig is board-certified in internal medicine, cardiology, and intensive care medicine with special interest in invasive and interventional cardiology. Dr Koenig has published more than 200 research papers in journals including Nature, The Lancet, Circulation, the British Medical Journal, and the European Heart Journal.

Dr Koenig`s research interests involve the molecular basis of atherothrombo­genesis including genetics with particular interest in the interrelations between hemostasis, inflammation, and atherothrombotic complications / type 2 diabetes, the metabolic syndrome, the clinical pharmacology of cardiovascular…

View full profile